NEW YORK (GenomeWeb News) – German life sciences company Eppendorf has filed a lawsuit against Nanosphere alleging that it is infringing a patent that covers its microarray technology.

Eppendorf said today that it has filed the suit in the US District Court for the District of Delaware against Northbrook, Ill.-based Nanosphere, claiming that it has willfully infringed on a patent covering its Silverquant microarray technology, which is offered in its Silverquant scanner and detection kit and has been licensed to two companies for commercialization.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.